|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 29770 |
FusionGeneSummary for PXN_PLA2G1B |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: PXN_PLA2G1B | Fusion gene ID: 29770 | Hgene | Tgene | Gene symbol | PXN | PLA2G1B | Gene ID | 7837 | 5319 |
| Gene name | peroxidasin | phospholipase A2 group IB | |
| Synonyms | ASGD7|COPOA|D2S448|D2S448E|MG50|PRG2|PXN|VPO | PLA2|PLA2A|PPLA2 | |
| Cytomap | 2p25.3 | 12q24.31 | |
| Type of gene | protein-coding | protein-coding | |
| Description | peroxidasin homologmelanoma-associated antigen MG50p53-responsive gene 2 proteinvascular peroxidase 1 | phospholipase A2phosphatidylcholine 2-acylhydrolase 1Bphospholipase A2, group IB (pancreas) | |
| Modification date | 20180523 | 20180519 | |
| UniProtAcc | P49023 | P04054 | |
| Ensembl transtripts involved in fusion gene | ENST00000458477, ENST00000228307, ENST00000424649, ENST00000397506, ENST00000536957, ENST00000267257, ENST00000538144, | ENST00000308366, ENST00000423423, ENST00000549767, | |
| Fusion gene scores | * DoF score | 7 X 4 X 10=280 | 5 X 3 X 7=105 |
| # samples | 11 | 7 | |
| ** MAII score | log2(11/280*10)=-1.34792330342031 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/105*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: PXN [Title/Abstract] AND PLA2G1B [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | PXN | GO:0030198 | extracellular matrix organization | 19590037 |
| Hgene | PXN | GO:0042744 | hydrogen peroxide catabolic process | 18929642 |
| Hgene | PXN | GO:0055114 | oxidation-reduction process | 18929642 |
| Tgene | PLA2G1B | GO:0002227 | innate immune response in mucosa | 12860195 |
| Tgene | PLA2G1B | GO:0006633 | fatty acid biosynthetic process | 1918029 |
| Tgene | PLA2G1B | GO:0008284 | positive regulation of cell proliferation | 1918029 |
| Tgene | PLA2G1B | GO:0016042 | lipid catabolic process | 7060561 |
| Tgene | PLA2G1B | GO:0019731 | antibacterial humoral response | 12860195 |
| Tgene | PLA2G1B | GO:0046470 | phosphatidylcholine metabolic process | 7060561 |
| Tgene | PLA2G1B | GO:0048146 | positive regulation of fibroblast proliferation | 1918029 |
| Tgene | PLA2G1B | GO:0050830 | defense response to Gram-positive bacterium | 12860195 |
| Tgene | PLA2G1B | GO:0061844 | antimicrobial humoral immune response mediated by antimicrobial peptide | 12860195 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | ACC | TCGA-OR-A5LO-01A | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| TCGA | RV | ESCA | TCGA-L5-A891-01A | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| TCGA | RV | KIRP | TCGA-SX-A7SM-01A | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000458477 | ENST00000308366 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| intron-3CDS | ENST00000458477 | ENST00000423423 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| intron-5UTR | ENST00000458477 | ENST00000549767 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| Frame-shift | ENST00000228307 | ENST00000308366 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| Frame-shift | ENST00000228307 | ENST00000423423 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| 5CDS-5UTR | ENST00000228307 | ENST00000549767 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| Frame-shift | ENST00000424649 | ENST00000308366 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| Frame-shift | ENST00000424649 | ENST00000423423 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| 5CDS-5UTR | ENST00000424649 | ENST00000549767 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| intron-3CDS | ENST00000397506 | ENST00000308366 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| intron-3CDS | ENST00000397506 | ENST00000423423 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| intron-5UTR | ENST00000397506 | ENST00000549767 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| intron-3CDS | ENST00000536957 | ENST00000308366 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| intron-3CDS | ENST00000536957 | ENST00000423423 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| intron-5UTR | ENST00000536957 | ENST00000549767 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| Frame-shift | ENST00000267257 | ENST00000308366 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| Frame-shift | ENST00000267257 | ENST00000423423 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| 5CDS-5UTR | ENST00000267257 | ENST00000549767 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| intron-3CDS | ENST00000538144 | ENST00000308366 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| intron-3CDS | ENST00000538144 | ENST00000423423 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| intron-5UTR | ENST00000538144 | ENST00000549767 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120763823 | - |
| intron-3CDS | ENST00000458477 | ENST00000308366 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| intron-3CDS | ENST00000458477 | ENST00000423423 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| intron-3CDS | ENST00000458477 | ENST00000549767 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| Frame-shift | ENST00000228307 | ENST00000308366 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| In-frame | ENST00000228307 | ENST00000423423 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| Frame-shift | ENST00000228307 | ENST00000549767 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| Frame-shift | ENST00000424649 | ENST00000308366 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| In-frame | ENST00000424649 | ENST00000423423 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| Frame-shift | ENST00000424649 | ENST00000549767 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| intron-3CDS | ENST00000397506 | ENST00000308366 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| intron-3CDS | ENST00000397506 | ENST00000423423 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| intron-3CDS | ENST00000397506 | ENST00000549767 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| intron-3CDS | ENST00000536957 | ENST00000308366 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| intron-3CDS | ENST00000536957 | ENST00000423423 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| intron-3CDS | ENST00000536957 | ENST00000549767 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| Frame-shift | ENST00000267257 | ENST00000308366 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| In-frame | ENST00000267257 | ENST00000423423 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| Frame-shift | ENST00000267257 | ENST00000549767 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| intron-3CDS | ENST00000538144 | ENST00000308366 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| intron-3CDS | ENST00000538144 | ENST00000423423 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
| intron-3CDS | ENST00000538144 | ENST00000549767 | PXN | chr12 | 120703420 | - | PLA2G1B | chr12 | 120760120 | - |
Top |
FusionProtFeatures for PXN_PLA2G1B |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| PXN | PLA2G1B |
| Cytoskeletal protein involved in actin-membraneattachment at sites of cell adhesion to the extracellular matrix(focal adhesion). | PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides, this releasesglycerophospholipids and arachidonic acid that serve as theprecursors of signal molecules. {ECO:0000269|PubMed:19297324}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for PXN_PLA2G1B |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for PXN_PLA2G1B |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| PXN | PTPN12, TRIP6, BCAR1, CRKL, RAB8B, GIT1, ARHGAP5, RASA1, PTK2, GIT2, PTK2B, TGFB1I1, PPP2CA, ITGA4, LCK, PKLR, ASAP2, VCL, NCK1, PABPC1, IGF1R, MATK, NF2, CRK, GRB2, SRC, TLN1, GSN, ILK, PTPRH, SYK, ITGB3, CEACAM1, NEDD9, BCR, CSK, PTEN, TUBG1, FYN, ITGB1, ASAP1, CBL, ITGAV, CTTN, IGBP1, NUDCD2, DSTN, FN1, RNF5, XPO1, AHCY, DGUOK, GART, POLR1D, CREB3L2, NAA10, CHMP5, SEC23B, ZYX, SEC24D, IQGAP1, ADAM17, ADAM10, SHMT2, MOV10, NXF1, ALK, HDAC6, EXOSC8, LIMS1, RABGGTB, TRIM15, CAP1, ASNS, GALE, PICALM, SELE, PIK3R1, MAPK1, RHOU, PAK4, CDH1, DFNB31, ARF1 | PLA2G1B | PLA2G2A, SOCS2 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for PXN_PLA2G1B |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Tgene | PLA2G1B | P04054 | DB00795 | Sulfasalazine | Phospholipase A2 | small molecule | approved |
| Tgene | PLA2G1B | P04054 | DB02659 | Cholic Acid | Phospholipase A2 | small molecule | approved |
| Tgene | PLA2G1B | P04054 | DB04552 | Niflumic Acid | Phospholipase A2 | small molecule | approved |
Top |
RelatedDiseases for PXN_PLA2G1B |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | PXN | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
| Hgene | PXN | C0025205 | Melanoma, Experimental | 1 | CTD_human |
| Hgene | PXN | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
| Tgene | PLA2G1B | C0005586 | Bipolar Disorder | 5 | PSYGENET |
| Tgene | PLA2G1B | C0036341 | Schizophrenia | 3 | PSYGENET |
| Tgene | PLA2G1B | C0525045 | Mood Disorders | 2 | PSYGENET |
| Tgene | PLA2G1B | C0338715 | Drug-induced depressive state | 1 | PSYGENET |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|